Inflammatory bowel diseases (IBD) are multifactorial disorders characterised by the host's inability to limit the inflammatory response to luminal antigens. The association of polymorphisms in the CARD15 gene with Crohn's disease (CD) demonstrates the relevance of activated transcription factor NF k B in mononuclear cells. Interleukin 11 (IL11) mediates anti-inflammatory effects and is able to downregulate LPS-induced NF k B activation. The IL11 gene is therefore a good candidate involved in genetic predisposition to IBD. To evaluate the role of the IL11 gene in IBD, two polymorphisms, including a dinucleotide repeat in the promoter region, have been genotyped in 222 patients with CD, 152 patients with ulcerative colitis (UC) and 400 healthy controls. PCR-SSCP analysis of the coding region revealed a single polymorphism in exon 4 leading to an amino acid exchange (G335A; R112H), not significantly associated with either disease. Dinucleotide repeat frequencies of the IL11.A1 allele and of IL11.A1 homozygous individuals were significantly increased among the patients with UC (Po0.002 and (Po0.003, respectively) but not with CD. Altered expression of IL11 appears to be involved in the genetic predisposition of UC.
Inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC) are characterised by destructive inflammation of the intestinal wall. An imbalanced immune response to luminal antigens and activation of the transcription factor NF k B seems to be crucial in the pathogenesis of IBD. [1] [2] [3] [4] NF k B leads to subsequent production of proinflammatory cytokines. Contributions of genetic factors to the predisposition to IBD have been proven, both by genetic linkage analyses and via epidemiological studies. 5, 6 The CARD15 gene (coding for NOD2 protein) on chromosome 16q12 has been identified recently as a predisposing gene for CD, but not for UC. 7, 8 NOD2 is involved in lipopolysaccharide (LPS)-induced activation of NF k B in monocytes. 9 Genes involved in the regulation of NF k B expression are therefore candidate genes for the predisposition to IBD.
Interleukin 11 (IL 11) is a pleiotropic cytokine produced by bone marrow stromal cells and other mesenchymal cells. 10 A wide range of inflammatory and anti-inflammatory effects has been described including downregulation of Th 1 -derived cytokines.
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Cytoprotective effects of IL 11 have been shown on the mucosa of the bowel. 12,13 IL 11 downregulates LPSinduced cytokine production of macrophages through inhibition of NF k B expression. 14 In order to evaluate whether altered expression of IL11 is involved in the pathogenesis of IBD, we genotyped a polymorphic dinucleotide repeat in the promoter of the IL 11 described by Bellingham et al. 15 Blood samples of 152 patients with UC and 222 patients with CD were collected at the university clinics of Bochum, Munich and Jena, Germany. Diagnoses were confirmed by clinical, endoscopical and histological parameters according to the diagnostic criteria as described by Lennard-Jones in 1989 and adapted by the European Community Workshop on IBD. 16 Ethnically matched control samples (including informed consent) from more than 400 healthy blood donors were described before. 17 DNA was isolated from EDTA-anticoagulated blood after standard protocols. 18 A novel allele (IL 11.A3: (GT) 8 (CT) 8 ) was identified. Frequencies of the IL 11.A1 allele and of IL11.A1 homozygous individuals were increased significantly among UC patients (Po0.002 and Po0.003, respectively; see Table 1 ), but not in CD.
To identify a putative predisposing polymorphism in the coding region of the IL11 gene, we screened each of the five exons in DNA samples including 20 patients with CD and 20 patients with UC, respectively. The IL11 gene is located on chromosome 19q13.4 and comprises about 7 kb of genomic DNA. SSCP analysis was performed under two different gel conditions for electrophoresis (see Table 2 ).
Restricted PCR products from exon 4 revealed a deviating SSCP profile in several patients. The profile was consistent with a sequence variation in heterozygous state. Direct sequencing of the purified PCR products confirmed a nucleotide exchange at position 335 (counted from the translation start) leading to an amino acid exchange (G335A; R112H). Genotype frequencies were determined by RFLP analyses with Hin6 1. The A allele is in linkage disequilibrium with the IL11.A1 allele (an IL11.A1 allele was present in all individuals heterozygous for the A allele). The frequency of the A allele was increased in UC without reaching statistical significance (see Table 3 ). This frequency is not able to serve as an exclusive explanation for the association of UC with the IL 11.A1 allele. No differences in SSCP profiles were observed in the other exons. However, linkage disequilibrium of the IL 11.A1
allele with an allele of a gene located in the same chromosomal region (e g hsp70-interacting protein or leukocyte receptor cluster (LRC) member 3) cannot be excluded.
As the dinucleotide repeat is located within the promoter of the IL11 gene, it might influence the transcription rate. Functional relevance of dinucleotide repeats in respect of the altered expression and protein binding characteristics have been demonstrated previously. 19, 20 Decreased expression of the anti-inflammatory cytokine IL 11 and a failure to downregulate NF k B expression could play an important role in the pathogenesis of UC. Our data support the hypothesis that genetic differences of the immune response are crucial in the etiology of IBD. Allele and haplotype frequencies were compared by the w 2 method; significance would be retained after correction for the number of alleles. Genotype frequencies of the control samples are in Hardy-Weinberg proportion. For polyacrylamide gel electrophoresis (PAGE) 3 ml of PCR product were mixed with 95% formamide, 20 mm EDTA, 0.05% xylene cyanol and 0.05% bromophenol blue. The samples were heated for 4 min at 951C. For each mix, 3 ml was run on 6% PAGE (38% acrylamide, 2% bisacrylamide) containing 1 Â TBE buffer and 8 m urea on a Base Ace sequencing apparatus (Stratagene) at constant 60 W at RT for 3 h. Gels were dried and subjected to autoradiography overnight. Allele lengths were determined by comparison with standard samples of known genotypes. Note: Longer PCR products were restricted with an endonuclease in order to generate optimal resolution of the banding patterns. For singlestrand conformation (SSCP) analyses, 3 ml of PCR product was mixed with 95% formamide, 10 mm NaOH, 20 mm EDTA, 0.02% xylene cyanol and 0.02% bromophenol blue. The samples were heated for 4 min at 951C and cooled on ice immediately. For each mix, 3 ml was run on two different PAGE gel systems (38% acrylamide, 2% bisacrylamide; gel condition 1: 10% glycerine; gel condition 2: 5% glycerine, 1m urea) containing 1 Â TBE buffer on a Base Ace sequencing apparatus (Stratagene) at constant 50 W in a 41C cold room for 3-6 h. Gels were dried and subjected to autoradiography overnight.
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Anti-inflammatory effects of recombinant human IL 11 (rhIL 11) have been demonstrated in human diseases. 21, 22 A beneficial effect of IL11 in respect of reducing clinical signs and histological lesions of colitis in transgenic rats has been shown. 23 Initial clinical trials have addressed the putative therapeutical effect of IL 11 in CD. 24 In case further association studies confirm these results and additional functional studies demonstrate the relevance of IL11 in the pathogenesis of UC, rh IL 11 should be evaluated in the therapy of UC as well. 
